Nuclera Extends Series C Funding to $87M to Advance Antibody Engineering
- Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh
- The funding will accelerate development of eProtein Discovery for full-format antibody expression, purification, and binding validation